Ascent Wealth Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
3,353
-834
| -20% | -$65.2K | 0.03% | 156 |
|
|
2025
Q1 | $303K | Buy |
4,187
+641
| +18% | +$46.5K | 0.04% | 152 |
|
|
2024
Q4 | $263K | Buy |
+3,546
| New | +$263K | 0.04% | 154 |
|
|
2024
Q3 | – | Sell |
-3,531
| Closed | -$326K | – | 160 |
|
|
2024
Q2 | $326K | Sell |
3,531
-113
| -3% | -$10.4K | 0.05% | 136 |
|
|
2024
Q1 | $348K | Hold |
3,644
| – | – | 0.05% | 143 |
|
|
2023
Q4 | $278K | Sell |
3,644
-105
| -3% | -$8.01K | 0.05% | 147 |
|
|
2023
Q3 | $260K | Buy |
3,749
+109
| +3% | +$7.55K | 0.05% | 147 |
|
|
2023
Q2 | $343K | Buy |
3,640
+632
| +21% | +$59.6K | 0.06% | 135 |
|
|
2023
Q1 | $249K | Sell |
3,008
-24
| -0.8% | -$1.99K | 0.05% | 140 |
|
|
2022
Q4 | $226K | Sell |
3,032
-278
| -8% | -$20.7K | 0.05% | 137 |
|
|
2022
Q3 | $274K | Buy |
+3,310
| New | +$274K | 0.07% | 125 |
|
|
2022
Q2 | – | Sell |
-3,160
| Closed | -$372K | – | 143 |
|
|
2022
Q1 | $372K | Sell |
3,160
-90
| -3% | -$10.6K | 0.07% | 120 |
|
|
2021
Q4 | $421K | Sell |
3,250
-132
| -4% | -$17.1K | 0.08% | 119 |
|
|
2021
Q3 | $383K | Sell |
3,382
-1
| -0% | -$113 | 0.07% | 128 |
|
|
2021
Q2 | $350K | Buy |
3,383
+211
| +7% | +$21.8K | 0.07% | 128 |
|
|
2021
Q1 | $265K | Buy |
3,172
+73
| +2% | +$6.1K | 0.06% | 111 |
|
|
2020
Q4 | $283K | Buy |
3,099
+328
| +12% | +$30K | 0.06% | 105 |
|
|
2020
Q3 | $221K | Buy |
+2,771
| New | +$221K | 0.06% | 103 |
|
|
2020
Q1 | – | Sell |
-3,228
| Closed | -$251K | – | 117 |
|
|
2019
Q4 | $251K | Buy |
3,228
+57
| +2% | +$4.43K | 0.07% | 107 |
|
|
2019
Q3 | $232K | Buy |
+3,171
| New | +$232K | 0.07% | 109 |
|
|
2019
Q2 | – | Sell |
-3,150
| Closed | -$201K | – | 128 |
|
|
2019
Q1 | $201K | Buy |
+3,150
| New | +$201K | 0.07% | 117 |
|